3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
16
Colonic Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Anus Neoplasms
2
Adenomatous Polyposis Coli
2
Turcot syndrome
1
Rectal Neoplasms
1
Polyps
1
Pathologic Complete Response
1
Lymphoma, Mantle-Cell
1
HIV Infections
1
Disease
1
Digestive System Diseases
1
Colon Cancer Screening
1
Colitis, Ulcerative
1
Benign Colorectal Neoplasm
1
Anal Canal Carcinoma
1
Adenoma
1
Interventions
Bevacizumab
2
trifluridine tipiracil drug combination
1
gadolinium ethoxybenzyl DTPA
1
gadobutrol
1
encorafenib
1
durvalumab
1
Urine Specimen Collection
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Oxaliplatin
1
Oviposition
1
Nivolumab
1
Levoleucovorin
1
Leucovorin
1
Irinotecan
1
Immunotherapy
1
IDRX-42
1
Hydromorphone
1
Fluorouracil
1
Fentanyl
1
Drug Therapy
1
Drainage
1
Dietary Supplements
1
Colonoscopy
1
Cetuximab
1
Capecitabine
1
Bupivacaine
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Digestive System Diseases
×
Colonoscopy
×
1 year
×
Clear all
NCT05612347
2026-05-07
COOP
Dartmouth-Hitchcock Medical Center
Phase NA
Recruiting
8,946 enrolled